Genmab A/S (GNMSF) Operating margin 2023–2025
Genmab A/S (GNMSF) operating margin by fiscal year — reported operating income divided by reported revenue.
28.6%FY2025 · since FY2023: 32.3% → 28.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 28.6% | -2.5 pp |
| FY2024 | 31.1% | -1.2 pp |
| FY2023 | 32.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice